By Hanna Vioque ( October 21, 2025, 7:58 PM BST) -- Incyte has fought back against the Indian pharmaceutical company Sun Pharma's bid to nix three patents protecting a blockbuster drug treating autoimmune conditions, arguing that once it launches in 2026, Sun Pharma's treatment for hair loss will infringe Incyte's intellectual property. ...
Incyte Claims Sun Pharma's Alopecia Drug Launch Violates IP

102